Cierra N. Sharp

Cierra N. Sharp

Aug 16, 2016

Group 6 Copy 17
0
    Please wait...

    About This Project

    A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute kidney injury (AKI) in 30% of patients. The aim of my project is to develop a mouse model that recapitulates the dosing regimen humans receive in order to develop and test novel renoprotective agents. This is important as there are no therapeutic interventions for cisplatin-induced AKI, and no long-term studies on kidney function have been performed in mice treated with cisplatin.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    How does lung fluke travel from snail to crab to human?

    Snails and crabs occupy the land-water ecotone across Africa, but very little is known about them. These...

    Conservation Efforts to Protect Endangered Turtles of Sulawesi

    Sulawesi, Indonesia, is home to many species found nowhere else on Earth. Although rich in biodiversity...

    Backer Badge Funded